Ellen Gordon

Ellen Gordon has a diverse work experience, starting their recent role as the VP, Head of Business Development at Almaden Genomics in May 2023. Ellen previously served as the VP Global Accounts at BrightInsight from May 2022 to May 2023. Ellen also held positions at Memorial Sloan Kettering Cancer Center as the Digital Ventures Lead - Business Development and Strategic Partnerships from October 2021 to May 2022, and at Genuity Science as the Vice President of Business Development from November 2020 to September 2021. Before that, they worked at GNS Healthcare as the Executive Director Business Development and later as the Principal, Client Solutions from May 2019 to November 2020. Prior to that, Ellen served as the Senior Vice President and Head of Research at RG+A from October 2017 to May 2019. Ellen'searlier roles include Vice President at AlphaImpactRx from March 2012 to October 2017, and Vice President at Market Strategies International from 2003 to 2012.

Ellen Gordon holds a Ph.D. in Political Science from the University of Michigan. Ellen obtained a BA in Politics from Brandeis University and an MA in Russian Area Studies from Georgetown University.